Helping you navigate at the intersection of policy and market access — focused on patient-first solutions.

Aery
Policy & Access
Partners

Aery Policy & Access Partners is a DC-based advisory consulting firm focused on today’s toughest pharmaceutical pricing and reimbursement issues, acting as a trusted advisor and facilitator of stakeholder solutions. Work is bespoke based on your specific concerns, building upon your existing strengths to facilitate optimal solutions.

My unique background spans roles
across various healthcare stakeholders.

Specialties

  • U.S. Government Payers at the Federal and State Levels

  • Drug Discounting and Rebating

  • 340B Subject Matter Expert

  • Policy Strategy Related to Drug Pricing or Market Access Concerns

  • Business Mitigation Solutions

  • Intersection of Global Drug Pricing and U.S. Evolving Policies

LEARN MORE

In the US and ex-US drug pricing environments, stakeholders are managing through an unprecedented amount of uncertainty as the rules and external environment are rapidly evolving.

Navigating Through Fog

Speaking Highlights

  • February 8, 2026
    Guest Lecturer

UPCOMING

  • November 19 - 20, 2025
    The 15th Annual Summit assist life sciences companies in delivering more effective forecasts, enhanced visibility, profitability and control through best practices for Gross-to-Net management.  
    Learn more >

  • November 13, 2025
    The BRG Washington Healthcare Policy Forum offers a dynamic half-day program featuring insights from Washington, DC, health policy leaders on key developments shaping 2026.  Topics include the Trump administration's policy and regulatory changes impacting healthcare investors, current priorities and challenges in Medicaid policy, emerging private equity trends, and more.
    Learn more >

  • October 22-24, 2025
    The Association for Value Based Cancer Care’s 15th Annual Summit brings together stakeholders and leaders for in-depth discussions, educations, and networking.
    learn more >

  • October 10, 2025
    A one-day convening of scholars, policymakers, advocates, and industry stakeholders to examine the early implementation of the Inflation Reduction Act’s drug pricing provisions, and celebrate the anniversary of Medicare Part D.
    learn more >

PREVIOUS